News
An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...
21h
MedPage Today on MSNSGLT2 Inhibitor Shows Promise as MASH TreatmentCurrently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...
Experts say semaglutide may be a much-needed treatment option for a liver disease with few current therapies. Ozempic is effective in treating a severe form of liver disease that affects millions ...
A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...
Researchers excluded participants who had other chronic liver problems besides nonalcoholic fatty liver disease ... treatment modalities. The study in the NEJM showing possible benefits of ...
Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...
Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results